Neurotrophic support in multiple sclerosis : exploring the therapeutic and biomarker potential of brain-derived neurotrophic factor
Source
Antwerpen, Universiteit Antwerpen, Faculteit Geneeskunde en Gezondheidswetenschappen,202 p.
Recent advances in interventions targeting remyelination and a systematic review of remyelinating effects of approved disease‐modifying treatments for multiple sclerosis
Source
European journal of neurology - ISSN 1351-5101-32:11 (2025) p. 1-19
AAV-mediated delivery of a proliferation inducing ligand (APRIL) to cortical neurons limits inflammation and demyelination in the corpus callosum of the cuprizone mouse model
Source
Journal of neuroinflammation - ISSN 1742-2094-22:1 (2025) p. 1-20
AAV-Based intracerebral administration of BDNF promotes myelin repair and cognitive improvement after cuprizone-induced demyelination
Source
Glia - ISSN 0894-1491-73:11 (2025) p. 2189-2205
The efficiency of brain-derived neurotrophic factor secretion by mRNA-electroporated regulatory T cells is highly impacted by their activation status
Source
European journal of immunology - ISSN 0014-2980-55:2 (2025) p. 1-13